New Cell Lines Produce NIST Monoclonal Antibody for Improved Manufacturing of Biologic Drugs | NIST

New Cell Lines Produce NIST Monoclonal Antibody for Improved Manufacturing of Biologic Drugs | NIST

New Cell Lines Produce NIST Monoclonal Antibody for Improved Manufacturing of Biologic Drugs

July 31, 2018

HeLa cancer cells appear green wherever mouse monoclonal antibodies (mAb) have bound to tubulin, a structural protein important in cell division. Binding to tubulin and preventing cell growth is one way that mAb drugs could kill tumors—the type of research that may benefit from the use of NIST's monoclonal antibody reference material, NISTmAb.

Credit: ©EnCor Biotechnology Inc.